Epidemiology of MPN: What Do We Know?

被引:0
作者
L. A. Anderson
M. F. McMullin
机构
[1] Queen’s University Belfast,Centre for Public Health
[2] Queen’s University Belfast,Centre for Cancer Research and Cell Biology
来源
Current Hematologic Malignancy Reports | 2014年 / 9卷
关键词
Epidemiology; Myeloproliferative neoplasms; Survival; Body mass index; Diet; Benzene;
D O I
暂无
中图分类号
学科分类号
摘要
The myeloproliferative neoplasms, are characterised by overproduction of myeloid cells. Chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, myelofibrosis and the very rare disorders chronic neutrophilic leukaemia, chronic eosinophilic leukaemia not otherwise specified and mastocytosis are all included in the group. Incidence and prevalence rates reported in the worldwide literature are presented in this review. Survival data on each condition is described. Information on the aetiology of the disorders is discussed including body mass index, diet, smoking and alcohol, allergies, associated medical conditions, occupation and environmental exposures with focus on recent new studies. The aetiology of the myeloproliferative neoplasms remains unknown, and this review of the current state of knowledge highlights the need for further comprehensive research.
引用
收藏
页码:340 / 349
页数:9
相关论文
共 372 条
[11]  
Levine RL(2011)Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay J Mol Diagn 13 180-109
[12]  
Pardanani AD(2004)Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence Hematol Oncol 22 91-5
[13]  
Levine RL(2004)Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99 J Intern Med 256 161-7
[14]  
Lasho T(2014)How common are myeloproliferative neoplasms? A systematic review and meta-analysis Am J Hematol 89 581-102
[15]  
Beer PA(2014)Leukemia incidence and survival in Germany according to current standardized categories Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57 93-7
[16]  
Campbell PJ(2013)Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009 Leuk Lymphoma 54 1411-34
[17]  
Scott LM(2009)The incidence of and mortality from leukaemias in the UK: a general population-based study BMC Cancer 9 252-63
[18]  
Grand FH(2010)Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project Blood 116 3724-7
[19]  
Hidalgo-Curtis CE(2014)Sex differences in the incidence of chronic myeloid leukemia Radiat Environ Biophys 53 55-5
[20]  
Ernst T(2012)Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy Cancer 118 3123-5